Exogenous NO triggers preconditioning via a cGMP- and mitoK ATP-dependent mechanism

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Qin, Qining ^a   Yang, Xi Ming ^a   Cui, Lin ^a   Critz, Stuart D ^b   Cohen, Michael V ^a   Browner, Natasha C ^a   Lincoln, Thomas M ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Guanylyl cyclase; Mitochondrial ATP sensitive potassium channel; Protein kinase G; S nitroso N acetylpenicillamine

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 5 HYDROXYDECANOIC ACID; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; FREE RADICAL; GUANYLATE CYCLASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; POTASSIUM CHANNEL; REACTIVE OXYGEN METABOLITE; TIOPRONIN; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MALE; MITOCHONDRIAL ATP SENSITIVE POTASSIUM CHANNEL; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC GMP; FEMALE; HEART; HEART VENTRICLES; HEMODYNAMIC PROCESSES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MEMBRANE PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; NITRIC OXIDE DONORS; POTASSIUM CHANNELS; RABBITS; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 3242703181     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00954.2003     Document Type: Article

References (53)

1. Aizawa T, Wei H, Miano JM, Abe J, Berk BC, and Yan C. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Circ Res 93: 406-413, 2003.
2. Altuǧ S, Demlryürek AT, Kane KA, and Kanzik I. Evidence for the involvement of peroxynitrite in ischaemic preconditioning in rat isolated hearts. Br J Pharmacol 130: 125-131, 2000.
3. ATP channels. J Cardiovasc Electrophysiol 10: 741-754, 1999.
4. Baines CP, Goto M, and Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 29: 207-216, 1997.
5. Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA, Smith TW, and Michel T. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 269: 27580-27588, 1994.
6. Baxter GF and Yellon DM. Delayed myocardial protection following ischaemic preconditioning. Basic Res Cardiol 91: 53-56, 1996.
7. 1-receptor activation in the rabbit. J Cardiovasc Pharmacol 29: 631-638, 1997.
8. Bell RM, Maddock HL, and Yellon DM. The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart. Cardiovasc Res 57: 405-415, 2003.
9. Bell RM and Yellon DM. The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. Cardiovasc Res 52: 274-280, 2001.
10. Bolli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guo Y, and Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81: 42-52, 1997.
11. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, and Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93: 325-338, 1998.
12. Brahmajothi MV and Campbell DL. Heterogeneous basal expression of nitric oxide synthase and superoxide dismutase isoforms in mammalian heart: implications for mechanisms governing indirect and direct nitric oxide-related effects. Circ Res 85: 575-587, 1999.
13. Butt E, Nolte C, Schulz S, Beltman J, Beavo JA, Jastorff B, and Walter U. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem Pharmacol 43: 2591-2600, 1992.
14. ATP channels. Circ Res 89: 273-278, 2001.
15. Csonka C, Szilvássy Z, Fülöp F, Páli T, Blasig IE, Tosaki A, Schulz R, and Ferdinandy P. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation 100: 2260-2266, 1999.
16. ATP channels in rat mitochondria. J Physiol 547: 893-902, 2003.
17. Dostmann WRG, Taylor MS, Nickl CK, Brayden JE, Frank R, and Tegge WJ. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Iα inhibit NO-induced cerebral dilation. Proc Natl Acad Sci USA 97: 14772-14777, 2000.
18. Draijer R, Vaandrager AB, Nolte C, de Jonge HR, Walter U, and van Hinsbergh VWM. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res 77: 897-905, 1995.
19. Forbes RA, Steenbergen C, and Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 88: 802-809, 2001.
20. Geiger J, Nolte C, Butt E, Sage SO, and Walter U. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci USA 89: 1031-1035, 1992.
21. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, and Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621, 1995.
22. + channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 283: H1545-H1554, 2002.
23. Harper JF and Brooker G. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2′0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res 1: 207-218, 1975.
24. Horimoto H, Saltman AE, Gaudette GR, and Krukenkamp IB. Nitric oxide-generating β-adrenergic blocker nipradilol preserves postischemic cardiac function. Ann Thorac Surg 68: 844-849, 1999.
25. + channels in cultured vascular smooth muscle cells. Circ Res 74: 471-476, 1994.
26. Layland J, Li JM, and Shah AM. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol 540: 457-467, 2002.
27. ATP channel. Am J Physiol Heart Circ Physiol 284: H299-H308, 2003.
28. Lefer DJ, Nakanishi K, Johnston WE, and Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88: 2337-2350, 1993.
29. Lochner A, Marais E, Genade S, and Moolman JA. Nitric oxide: a trigger for classic preconditioning? Am J Physiol Heart Circ Physiol 279: H2752-H2765, 2000.
30. Lu HR, Remeysen P, and De Clerck F. Does the antiarrhythmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway? J Cardiovasc Pharmacol 25: 524-530, 1995.
31. Miki T, Cohen MV, and Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 186: 3-12, 1998.
32. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
33. Nakanishi K, Vinten-Johansen J, Lefer DJ, Zhao Z, Fowler WC III, McGee DS, and Johnston WE. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol Heart Circ Physiol 263: H1650-H1658, 1992.
34. Nakano A, Liu GS, Heusch G, Downey JM, and Cohen MV. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 32: 1159-1167, 2000.
35. a.National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: Natl. Acad. Press, 1996.
36. ATP channels in rabbits. Am J Physiol Heart Circ Physiol 283: H1263-H1269, 2002.
37. ATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 286: H468-H476, 2004.
38. ATP channels triggers the preconditioned state by generating free radicals. Circ Res 87: 460-466, 2000.
39. Rakhit RD, Edwards RJ, Mockridge JW, Baydoun AR, Wyatt AW, Mann GE, and Marber MS. Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes. Am J Physiol Heart Circ Physiol 278: H1211-H1217, 2000.
40. Sasaki N, Sato T, Ohler A, O'Rourke B, and Marbán E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101: 439-445, 2000.
41. Schulz R, Kelm M, and Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61: 402-413, 2004.
42. Schulz R and Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res 30: 432-439, 1995.
43. + channel openers in guinea-pig ventricular cells. Br J Pharmacol 120: 1568-1574, 1997.
44. Sun W and Wainwright CL. The role of nitric oxide in modulating ischaemia-induced arrhythmias in rats. J Cardiovasc Pharmacol 29: 554-562, 1997.
45. Takano H, Tang XL, Qiu Y, Guo Y, French BA, and Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res 83: 73-84, 1998.
46. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, De Simone C, Violante A, Esposito A, Chiariello M, and Ambrosio G. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 80: 743-748, 1997.
47. Vegh A, Szekeres L, and Parratt J. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 107: 648-652, 1992.
48. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, and Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84: 1020-1031, 1999.
49. Wall TM, Sheehy R, and Hartman JC. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 270: 681-689, 1994.
50. Weselcouch EO, Baird AJ, Sleph P, and Grover GJ. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol Heart Circ Physiol 268; H242-H249, 1995.
51. Woolfson RG, Patel VC, Neild GH, and Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91: 1545-1551, 1995.
52. Yao Z, Tong J, Tan X, Li C, Shao Z, Kim WC, Vanden Hoek TL, Becker LB, Head CA, and Schumacker PT. Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes. Am J Physiol Heart Circ Physiol 277: H2504-H2509, 1999.
53. Yasmin W, Strynadka KD, and Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 33: 422-432, 1997.